Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Obstructive Lung Diseases

Free Subscription Articles published in Ann Allergy Asthma Immunol Retrieve available abstracts of 220 articles: HTML format

Single Articles

October 2026
1. RIJAVEC M, Svetina M, Skrgat S, Zidarn M, et al
   Hereditary alpha-tryptasemia is associated with response to omalizumab in severe allergic asthma.
   Ann Allergy Asthma Immunol. 2026 Oct 15:S1081-1206(26)01271.
   PubMed     Abstract available
   
   
   
2. MICHEALS K, Nguyen W, Alwesabi Y
   Explainable Machine Learning to Identify Clinical, Environmental, and Social Factors Associated with Diagnosed Pediatric Asthma.
   Ann Allergy Asthma Immunol. 2026 Oct 5:S1081-1206(26)01210.
   PubMed     Abstract available
   
   
   
3. LEE JY, Kim HB, Shamakhi R, Choi HS, et al
   Identifying high-risk patients for recurrence in eosinophilic nasal polyposis: A multicenter cohort study.
   Ann Allergy Asthma Immunol. 2026;137:471-476.
   PubMed     Abstract available
   
   
   
4. FREDERICK RM, Lam K, Han JK
   Cellular and immune mechanisms of acute exacerbations of chronic rhinosinusitis.
   Ann Allergy Asthma Immunol. 2026;137:436-440.
   PubMed     Abstract available
   
   
   
5. SUTER P, Greig R, Stewart K, Lipworth BJ, et al
   Impact of dupilumab on Sino-Nasal Outcome Test-22 (SNOT-22) domains: Focus on the ear.
   Ann Allergy Asthma Immunol. 2026;137:477-482.
   PubMed     Abstract available
   
   
   September 2026
6. ORANGE JS, Chinen J, Horner CC, Kobrynski LJ, et al
   Corrigendum to '2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI)
   Ann Allergy Asthma Immunol. 2026 Sep 28:S1081-1206(26)00390.
   PubMed    
   
   
   
7. YU Z, Gao M, Liu B, Yao J, et al
   Clinical remission in asthma: from symptom control to disease modification.
   Ann Allergy Asthma Immunol. 2026 Sep 24:S1081-1206(26)01198.
   PubMed     Abstract available
   
   
   
8. DEMARTINO JK, Ambrose CS, Sanchez SZ, Emmanuel B, et al
   Real-World Effectiveness of Tezepelumab for Patients with Severe Asthma in the United States: CROSSROADS-3.
   Ann Allergy Asthma Immunol. 2026 Sep 17:S1081-1206(26)01199.
   PubMed     Abstract available
   
   
   
9. KIM SL, Mansur JI, Carr E, Kung N, et al
   An IL-6 high phenotype in children with asthma is associated with obesity and neutrophilia.
   Ann Allergy Asthma Immunol. 2026 Sep 14:S1081-1206(26)01177.
   PubMed     Abstract available
   
   
   
10. INGRAM I, Kloepfer K, Jin J, Krupp N, et al
    "Factors Impacting Transition to Adult Care for Patients Seen in a Pediatric Severe Asthma Clinic".
    Ann Allergy Asthma Immunol. 2026 Sep 13:S1081-1206(26)01181.
    PubMed    
    
    
    
11. LIAN D, Lin C, Wei J, Tang Q, et al
    Household food hardship and asthma morbidity among United States children with current asthma.
    Ann Allergy Asthma Immunol. 2026 Sep 12:S1081-1206(26)00450.
    PubMed     Abstract available
    
    
    
12. YOSHIZATO R, Motomura Y, Fujita T, Babazono A, et al
    Corrigendum to 'Secondhand smoking and pediatric asthma after respiratory syncytial virus or human metapneumovirus infection' [Annals of Allergy, Asthma & Immunology. Volumne 132, Issue 2 (2024), Pages 240-242].
    Ann Allergy Asthma Immunol. 2026 Sep 11:S1081-1206(26)00440.
    PubMed    
    
    
    
13. PETERS AT, Adappa ND, Chandra RK, Davis GE, et al
    Exhalation Delivery System with Fluticasone in Chronic Rhinosinusitis by Eosinophil, Asthma, and Allergy Status.
    Ann Allergy Asthma Immunol. 2026 Sep 3:S1081-1206(26)00423.
    PubMed     Abstract available
    
    
    August 2026
14. MENZELLA F, Pelaia C, Marchi MR, Ventura L, et al
    Sustained clinical remission over 24 months with tezepelumab in real-world severe uncontrolled asthma.
    Ann Allergy Asthma Immunol. 2026 Aug 28:S1081-1206(26)00417.
    PubMed    
    
    
    
15. BACHELIER LB, Chipps BE, Coyne KS, Eudicone JM, et al
    Pediatric Asthma Impairment and Risk Questionnaire identifies children most at risk for exacerbation.
    Ann Allergy Asthma Immunol. 2026 Aug 26:S1081-1206(26)00413.
    PubMed     Abstract available
    
    
    
16. ZHA W, Cai J
    Small-airway dysfunction in well-controlled pediatric asthma: Definitions and inferences require clarification.
    Ann Allergy Asthma Immunol. 2026 Aug 26:S1081-1206(26)00360.
    PubMed    
    
    
    
17. SHEN YL, Fu PK, Lo PC, Su K, et al
    Impulse oscillometry reference values and small airway reversibility in the assessment of asthma.
    Ann Allergy Asthma Immunol. 2026 Aug 22:S1081-1206(26)00409.
    PubMed     Abstract available
    
    
    
18. YANG L, Vinturache A, Ding G
    Divergent Age-Specific Trends in Inhaled Corticosteroid Use Among US Individuals With Asthma, 2014-2023.
    Ann Allergy Asthma Immunol. 2026 Aug 21:S1081-1206(26)00411.
    PubMed    
    
    
    
19. COPPOLA S, Agizza A, Iorio RF, Carucci L, et al
    Obesity, Asthma and Allergy Triangle: The Solution could be the Diet.
    Ann Allergy Asthma Immunol. 2026 Aug 6:S1081-1206(26)00383.
    PubMed     Abstract available
    
    
    
20. MORACZEWSKI J, Bacharier LB
    Is Remission a Meaningful Outcome in Asthma?
    Ann Allergy Asthma Immunol. 2026 Aug 5:S1081-1206(26)00381.
    PubMed     Abstract available
    
    
    
21. LIM JV, Lipworth B, Menzella F, Usmani O, et al
    Improved peripheral airway reactance is associated with clinical remission following biologic therapy in severe asthma.
    Ann Allergy Asthma Immunol. 2026 Aug 3:S1081-1206(26)00364.
    PubMed     Abstract available
    
    
    
22. LEDFORD D, Wells R
    Sinusitis, asthma, and bronchiectasis: Are eosinophils the driver or just along for the ride?
    Ann Allergy Asthma Immunol. 2026;137:135-136.
    PubMed    
    
    
    
23. GREENBERGER PA
    On being smart in the early treatment of exacerbations of asthma.
    Ann Allergy Asthma Immunol. 2026;137:131-132.
    PubMed    
    
    
    
24. ESHGHI E, Ryan G, Goulding M, Spano M, et al
    Clinician and family perspectives on the use of single maintenance and reliever therapy for children.
    Ann Allergy Asthma Immunol. 2026;137:194-201.
    PubMed     Abstract available
    
    
    
25. CROCE E, Bhavnani D, Parast L, Micheals K, et al
    Socioeconomic status and acculturation as determinants of atopic disease prevalence in United States Latino children.
    Ann Allergy Asthma Immunol. 2026;137:176-184.
    PubMed     Abstract available
    
    
    July 2026
26. LUGOGO NL, Peters AT, Katial R, Chen C, et al
    High Systemic Corticosteroids Burden Among Moderate-to-Severe Asthma Patients in the United States.
    Ann Allergy Asthma Immunol. 2026 Jul 14:S1081-1206(26)00336.
    PubMed     Abstract available
    
    
    
27. COMBERIATI P, Cottini M, Ventura L, Lombardi C, et al
    Small airway dysfunction: a key predictor of exacerbation risk in adolescents with mild, well-controlled asthma.
    Ann Allergy Asthma Immunol. 2026 Jul 11:S1081-1206(26)00339.
    PubMed    
    
    
    
28. SHAN Q
    Co-occurrence of bronchiectasis among patients with chronic rhinosinusitis based on associated asthma.
    Ann Allergy Asthma Immunol. 2026 Jul 11:S1081-1206(26)00283.
    PubMed    
    
    
    
29. GROGAN CE, Elliott MR, Marshall GD Jr
    New Pharmaceutical Options for Patients with Allergic and Asthma-Related Diseases: Balancing Effectiveness and Safety in Selection of Specific Therapies.
    Ann Allergy Asthma Immunol. 2026 Jul 8:S1081-1206(26)00335.
    PubMed     Abstract available
    
    
    June 2026
30. SCHWORER SA, Lee JH, O'Neal WK
    Overlapping Mechanisms and Novel Biomarkers Define Asthma and COPD as a Spectrum of Airway Disease.
    Ann Allergy Asthma Immunol. 2026 Jun 30:S1081-1206(26)00292.
    PubMed     Abstract available
    
    
    
31. BALAGANI P, Jung Y, Field SS, Chhoet Z, et al
    Small Airway Dysfunction and Prior Exacerbations are Common in Primarily Well-Controlled Pediatric Asthma.
    Ann Allergy Asthma Immunol. 2026 Jun 28:S1081-1206(26)00308.
    PubMed     Abstract available
    
    
    
32. KWON M, Dicker S, Mustafa N, Arora S, et al
    Generative Artificial Intelligence and Prompt Engineering in Asthma-Related Settings.
    Ann Allergy Asthma Immunol. 2026 Jun 25:S1081-1206(26)00291.
    PubMed     Abstract available
    
    
    
33. ELMOURSI A, Zhang L, Maus MV, Barmettler S, et al
    Reductions in Immunoglobulin Levels, Atopic Disease, and Asthma Following CAR T-Cell Therapy.
    Ann Allergy Asthma Immunol. 2026 Jun 12:S1081-1206(26)00269.
    PubMed    
    
    
    
34. CHENG Y, Qian Z, Wang R, Liang Y, et al
    Predictive value of the Hemoglobin, Albumin, Lymphocyte, and Platelet score for mortality in asthma.
    Ann Allergy Asthma Immunol. 2026 Jun 3:S1081-1206(26)00259.
    PubMed     Abstract available
    
    
    
35. DAULAT S
    Small airways dysfunction in asthma: Role of diet?
    Ann Allergy Asthma Immunol. 2026;136:718.
    PubMed    
    
    
    May 2026
36. BOUGHER C, Raval D, Thomas S, Abuqubo R, et al
    Co-occurrence of Bronchiectasis Among Chronic Rhinosinusitis Patients Based on Associated Asthma.
    Ann Allergy Asthma Immunol. 2026 May 31:S1081-1206(26)00233.
    PubMed     Abstract available
    
    
    
37. GRONNIER M, Ramakrishnan S, Beasley RW, Pavord ID, et al
    After the escalator: narrative review of biomarker-guided asthma care.
    Ann Allergy Asthma Immunol. 2026 May 27:S1081-1206(26)00231.
    PubMed     Abstract available
    
    
    
38. CLARION J, Berill Z, Susi A, Mitre E, et al
    Post-COVID-19 Onset of Allergic Conditions in a Propensity-Matched Cohort of Children and Adults.
    Ann Allergy Asthma Immunol. 2026 May 25:S1081-1206(26)00227.
    PubMed     Abstract available
    
    
    
39. BUSSE WW, Castro M, Lugogo NL, O'Byrne PM, et al
    Improved asthma outcomes for dupilumab plus medium-dose inhaled corticosteroids versus placebo plus high-dose inhaled corticosteroids.
    Ann Allergy Asthma Immunol. 2026 May 23:S1081-1206(26)00223.
    PubMed     Abstract available
    
    
    
40. BOURDIN A, Pavord ID, Ballew N, Butcher B, et al
    Depemokimab reduces asthma exacerbations similarly to other biologics: systematic trial review and indirect treatment comparison.
    Ann Allergy Asthma Immunol. 2026 May 21:S1081-1206(26)00218.
    PubMed     Abstract available
    
    
    
41. BINGEMANN TA
    ACAAI/ AAP Symposium -What was served in the last year: Food Allergy Non-treatment.
    Ann Allergy Asthma Immunol. 2026 May 19:S1081-1206(26)00216.
    PubMed     Abstract available
    
    
    
42. LANZ MJ, Cespedes LH, Chartrand EM, Eisenlohr CP, et al
    Utility of Exhaled Nitric Oxide as a Potential Biomarker in Non-Asthmatics with Multiple Food Allergies.
    Ann Allergy Asthma Immunol. 2026 May 11:S1081-1206(26)00196.
    PubMed    
    
    
    
43. OPPENHEIMER JJ
    What's new in the care of patients with asthma?
    Ann Allergy Asthma Immunol. 2026;136:501.
    PubMed    
    
    
    
44. SUTER P, Greig R, Lipworth BJ
    Bucher indirect treatment comparison of phase 3 trials with dupilumab and tezepelumab in chronic rhinosinusitis with nasal polyps.
    Ann Allergy Asthma Immunol. 2026;136:589-595.
    PubMed     Abstract available
    
    
    
45. LIPWORTH B, Zambelli E, Agazzi R, Piraino A, et al
    Relative particle size and distribution of inhaled triple therapies.
    Ann Allergy Asthma Immunol. 2026;136:545-549.
    PubMed     Abstract available
    
    
    April 2026
46. COUILLARD S, Petousi N, Ramakrishnan S, Valle R, et al
    Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asth
    Ann Allergy Asthma Immunol. 2026 Apr 10:S1081-1206(26)00150.
    PubMed     Abstract available
    
    
    
47. ABD AE, Trottier H, Tse SM, Masse B, et al
    Impact of vitamin D status and supplementation on exploratory inflammatory biomarkers in preschoolers with asthma.
    Ann Allergy Asthma Immunol. 2026 Apr 9:S1081-1206(26)00128.
    PubMed     Abstract available
    
    
    
48. HAKANSSON KEJ, Hansen S, Soendergaard MB, Sverrild A, et al
    Five-year inhaled, systemic and total corticosteroid exposure reduction during anti-Interleukin-5/Ralpha treatment for severe asthma.
    Ann Allergy Asthma Immunol. 2026 Apr 3:S1081-1206(26)00148.
    PubMed     Abstract available
    
    
    
49. LUGOGO NL, Silver J, Busse WW, Laliberte F, et al
    Mepolizumab Demonstrates Quantifiable Reduction in Corticosteroid-Related Adverse Effects in Severe Asthma.
    Ann Allergy Asthma Immunol. 2026 Apr 3:S1081-1206(26)00146.
    PubMed     Abstract available
    
    
    
50. ORANGE JS, Chinen J, Horner CC, Kobrynski LJ, et al
    2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical
    Ann Allergy Asthma Immunol. 2026;136:426-493.
    PubMed    
    
    
    March 2026
51. MARQUES-MEJIAS A, Bartha I, Ciaccio CE, Chinthrajah RS, et al
    Corrigendum to 'Skin as the target for allergy prevention and treatment' [Annals of Allergy, Asthma & Immunology, Volume 133, Issue 2 (2024) 133-143].
    Ann Allergy Asthma Immunol. 2026 Mar 28:S1081-1206(26)00116.
    PubMed    
    
    
    
52. XIAO Z, Zhang H, Peng Y, Zheng R, et al
    A single-cell atlas of the human airways from patients with allergic rhinitis comorbid with asthma.
    Ann Allergy Asthma Immunol. 2026 Mar 24:S1081-1206(26)00119.
    PubMed     Abstract available
    
    
    
53. MCCANN WA, Chipps BE, Beuther DA, Zeiger RS, et al
    Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severities.
    Ann Allergy Asthma Immunol. 2026 Mar 22:S1081-1206(26)00120.
    PubMed     Abstract available
    
    
    
54. HAN YY, Yue M, Pereira K, Rosser FJ, et al
    Persistent exposure to second-hand smoke and asthma endotypes in a study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2026 Mar 22:S1081-1206(26)00118.
    PubMed     Abstract available
    
    
    
55. GREIMANN E, Lin CH, Freigeh G, Nelson B, et al
    Treatment for Mild Asthma: What Matters to Providers.
    Ann Allergy Asthma Immunol. 2026 Mar 10:S1081-1206(26)00096.
    PubMed     Abstract available
    
    
    
56. ADGENT MA, Gebretsadik T, Moore PE, Hartman TJ, et al
    Gestational diabetes and childhood lung function at age 8 to 9 years in a diverse US cohort.
    Ann Allergy Asthma Immunol. 2026;136:282-287.
    PubMed     Abstract available
    
    
    February 2026
57. CHEN R, Talapatra K, Ali S, Lyu J, et al
    Effect of background asthma and allergic conditions on prophylaxis and treatment of COVID-19 infection.
    Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00070.
    PubMed     Abstract available
    
    
    
58. COYLE L, McDowell PJ, Heaney LG
    Lessons learned regarding optimal use of biologics to achieve disease remission in severe asthma.
    Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00069.
    PubMed     Abstract available
    
    
    
59. KHARBANDA S, Stocker L, Rupani H
    Asthma in pregnancy: optimising treatment strategies and the emerging role of biologic therapies.
    Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00071.
    PubMed     Abstract available
    
    
    
60. BOZEK A, Urbaniec E, Miodonska M, Scierski W, et al
    Efficacy of Omalizumab in Moderate Chronic Rhinosinusitis With Nasal Polyps and Immunoglobulin E-Mediated Asthma.
    Ann Allergy Asthma Immunol. 2026 Feb 27:S1081-1206(26)00073.
    PubMed     Abstract available
    
    
    
61. ERKMAN JL, Nowak-Wegrzyn A, Joseph S, Kesebir D, et al
    Aerodigestive eosinophils in children with severe uncontrolled asthma.
    Ann Allergy Asthma Immunol. 2026 Feb 14:S1081-1206(26)00058.
    PubMed    
    
    
    
62. LUGOGO NL, Han JK, Peters AT, Lee SE, et al
    Tezepelumab's effects on patient-reported symptoms in severe asthma, overall and with history of comorbid CRSwNP.
    Ann Allergy Asthma Immunol. 2026 Feb 13:S1081-1206(26)00057.
    PubMed     Abstract available
    
    
    
63. GUPTA MR, Bingemann TA
    Who actually has asthma? The challenge of defining and diagnosing asthma.
    Ann Allergy Asthma Immunol. 2026;136:125-126.
    PubMed    
    
    
    January 2026
64. ROBILLARD K, Crooks JL, Leung D, Hui-Beckman JW, et al
    LABA Use in Asthmatics is Not Associated with an Increased Severity of OFC Reactions.
    Ann Allergy Asthma Immunol. 2026 Jan 18:S1081-1206(26)00023.
    PubMed    
    
    
    
65. SUZUKAWA M, Ohta K, Hashimoto H, Oyamada Y, et al
    Corrigendum to 'Characterization and cluster analyses of elderly asthma in comparison with non-elderly asthma patients in Japan' [Annals of Allergy, Asthma & Immunology, Volume 130, Issue 5 (2023) 607-616.e3].
    Ann Allergy Asthma Immunol. 2026 Jan 14:S1081-1206(25)01382.
    PubMed    
    
    
    
66. HANNA ME, Ledford DK
    As-needed plus maintenance inhaled corticosteroid for asthma management: A safe, not excessive treatment strategy.
    Ann Allergy Asthma Immunol. 2026;136:3-4.
    PubMed    
    
    
    
67. TUNCERLER G, Bese SA, Sahin C, Torer N, et al
    Fresh clothes, hard breaths: Laundry washing habits, detergents, softeners, and impaired respiratory functions in children with wheezing.
    Ann Allergy Asthma Immunol. 2026;136:85-91.
    PubMed     Abstract available
    
    
    December 2025
68. SHER ER, Golant A, de Bruin-Weller M, Carrascosa JM, et al
    Lebrikizumab is Efficacious in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Regardless of Atopic Comorbidities.
    Ann Allergy Asthma Immunol. 2025 Dec 21:S1081-1206(25)01389.
    PubMed     Abstract available
    
    
    
69. HUSSEY V, Cottini M, Chan R, Galant SP, et al
    Beyond the asthma guidelines: look under the hood, particularly in those considered well controlled.
    Ann Allergy Asthma Immunol. 2025 Dec 11:S1081-1206(25)01380.
    PubMed    
    
    
    
70. WATKINSON RL, Montgomery ST, Berry L, Gwatimba A, et al
    A differentiated nasal epithelial cell model derived from children with acute wheeze and asthma.
    Ann Allergy Asthma Immunol. 2025 Dec 10:S1081-1206(25)01378.
    PubMed     Abstract available
    
    
    
71. LEE Y, Chang JH, Kim C, Lee E, et al
    Clustering of patients with severe asthma based on long-term FEV1% changes: Real-world evidence.
    Ann Allergy Asthma Immunol. 2025 Dec 5:S1081-1206(25)01371.
    PubMed     Abstract available
    
    
    
72. HUSSIEN H, Moore DL, Nimri S, Bilaver LA, et al
    The Age of Eczema Onset and Multiple Food Allergies.
    Ann Allergy Asthma Immunol. 2025 Dec 3:S1081-1206(25)01369.
    PubMed     Abstract available
    
    
    
73. GRAYSON MH
    2025 American College of Allergy, Asthma and Immunology Annals fellow-in-training award winners: The future of allergy and immunology.
    Ann Allergy Asthma Immunol. 2025;135:614-615.
    PubMed    
    
    
    November 2025
74. CRAWFORD W, Puttock EJ, Zeiger RS, Schatz M, et al
    Statins Associate with Reduced Asthma Exacerbation Risk In Black and Obese Patients with Mild Asthma.
    Ann Allergy Asthma Immunol. 2025 Nov 28:S1081-1206(25)01365.
    PubMed    
    
    
    
75. SUZAKI I, Tanaka A, Teguchi S, Teguchi Y, et al
    Dupilumab achieves clinical remission of comorbid asthma in patients with high-burden eosinophilic chronic rhinosinusitis.
    Ann Allergy Asthma Immunol. 2025 Nov 21:S1081-1206(25)01357.
    PubMed     Abstract available
    
    
    October 2025
76. SALAS PS, Villareal DT, Tejwani V, Koirala A, et al
    Hyperglycemia, receptor for advanced glycation end products, and small airways dysfunction in asthma.
    Ann Allergy Asthma Immunol. 2025 Oct 24:S1081-1206(25)01290.
    PubMed     Abstract available
    
    
    
77. FELESZKO W, Caminati M, Gern JE, Johnston SL, et al
    Effect of tezepelumab on asthma exacerbations co-occurring with infection-attributed acute respiratory illnesses.
    Ann Allergy Asthma Immunol. 2025 Oct 8:S1081-1206(25)01201.
    PubMed     Abstract available
    
    
    
78. ARIUE B, Patel NC, Bellanti JA
    Lessons from the ACAAI IEI Survey: Advancing Diagnostic and Therapeutic Strategies for the Practicing Allergist-Immunologist.
    Ann Allergy Asthma Immunol. 2025 Oct 5:S1081-1206(25)01224.
    PubMed     Abstract available
    
    
    September 2025
79. KUNG TJ, Weng CF, Wu SC, Lin FJ, et al
    Comparative Effectiveness of Fixed-Dose ICS/LABA Therapy in Adult Patients with Asthma.
    Ann Allergy Asthma Immunol. 2025 Sep 29:S1081-1206(25)01205.
    PubMed     Abstract available
    
    
    
80. THOMPSON D, Visness CM, Wood RA, O'Connor GT, et al
    Associations between body weight, asthma burden, and T2 inflammation among under-resourced children.
    Ann Allergy Asthma Immunol. 2025 Sep 27:S1081-1206(25)01204.
    PubMed     Abstract available
    
    
    
81. AMADO C, Lopez-Padilla D, Mendez R, Martinez-Garcia MA, et al
    AIRWAY OVERLAP SYNDROMES WITH ASTHMA.
    Ann Allergy Asthma Immunol. 2025 Sep 18:S1081-1206(25)01168.
    PubMed     Abstract available
    
    
    
82. TIOTIU A, Pilette C, Bagnasco D, Bondi B, et al
    Comparative analysis of biologics' effects on lung function parameters in severe asthma.
    Ann Allergy Asthma Immunol. 2025 Sep 6:S1081-1206(25)01156.
    PubMed     Abstract available
    
    
    
83. JHANG YS, Chang HC, Gau SY
    Risk of asthma in US adults with COVID-19 in real-world settings.
    Ann Allergy Asthma Immunol. 2025;135:347-348.
    PubMed    
    
    
    
84. ABDELKADER S, Voladri DR, Kennedy JL
    Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.
    Ann Allergy Asthma Immunol. 2025;135:249-260.
    PubMed     Abstract available
    
    
    August 2025
85. PATERSON F, On JY, Ahmed D, Poto R, et al
    Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptoms.
    Ann Allergy Asthma Immunol. 2025 Aug 29:S1081-1206(25)00440.
    PubMed     Abstract available
    
    
    
86. GHABOUSIAN A, Bezerra GN, Zhu Z, Espinola JA, et al
    Impact of varying childhood asthma definitions on incidence and clinical outcomes.
    Ann Allergy Asthma Immunol. 2025 Aug 14:S1081-1206(25)00414.
    PubMed     Abstract available
    
    
    
87. KHEZRIAN M, Kerkhof M, Le TT, Harrison T, et al
    Adherence to inhaled corticosteroid medications following an asthma exacerbation and the risk of subsequent exacerbations.
    Ann Allergy Asthma Immunol. 2025 Aug 13:S1081-1206(25)00416.
    PubMed     Abstract available
    
    
    July 2025
88. GALLETTA F, Passanisi S, Randazzese SF, Licari A, et al
    Real-Life Evaluation of Biologics in Pediatric Severe Asthma Using Core Outcome Measures for Severe Asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 31:S1081-1206(25)00395.
    PubMed    
    
    
    
89. GREIG R, Chan R, Lipworth B
    Type 2 biomarkers and airway hyper-responsiveness disconnect in uncontrolled severe asthma patients taking benralizumab or dupilumab.
    Ann Allergy Asthma Immunol. 2025 Jul 26:S1081-1206(25)00379.
    PubMed    
    
    
    
90. CORONEL AC, Sanchez-Tamay NM, Ballena-Caicedo J, Zuzunaga-Montoya FE, et al
    Prevalence of asthma in adults in Latin America: a systematic review and meta-analysis.
    Ann Allergy Asthma Immunol. 2025 Jul 24:S1081-1206(25)00375.
    PubMed     Abstract available
    
    
    
91. ONGTENGCO A, Wilt E, Hardy P, Youssef C, et al
    "Getting in and doing it personally": Engagement Strategies for Rural School Asthma Programs.
    Ann Allergy Asthma Immunol. 2025 Jul 24:S1081-1206(25)00377.
    PubMed     Abstract available
    
    
    
92. MENDOZA LE, Casilang CG, Morphew T, Barrows J, et al
    Feasibility of Remote Patient Monitoring to Increase Inhaled Corticosteroid Adherence in Children with High-Risk Asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 23:S1081-1206(25)00369.
    PubMed     Abstract available
    
    
    
93. KAZANCIOGLU A, Ozdemiral C, Cetinkaya PG, Ocak M, et al
    Long-term risk of allergic diseases following allergic proctocolitis: A clinical perspective.
    Ann Allergy Asthma Immunol. 2025 Jul 21:S1081-1206(25)00371.
    PubMed     Abstract available
    
    
    
94. CHIPPS BE, Panettieri RA Jr, Skolnik N, Cappelletti C, et al
    Albuterol-budesonide rescue inhaler for asthma: patterns of use and safety in the MANDALA trial.
    Ann Allergy Asthma Immunol. 2025 Jul 13:S1081-1206(25)00348.
    PubMed     Abstract available
    
    
    
95. BUSSE WW
    Oh Eosinophil, what can you tell us about asthma?
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00347.
    PubMed     Abstract available
    
    
    
96. COTE A, Beach J, Reynolds J, Usuba K, et al
    ALERT (ChAracterizing uncontroLled sevERe asThma in Canada): oral corticosteroid and short-acting beta(2)-agonist overuse.
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00346.
    PubMed     Abstract available
    
    
    
97. MAHMOOD LZ, Perry TT, Jefferson AA, Berlinski A, et al
    Implications of removing race from spirometry reference equations in children with asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00343.
    PubMed     Abstract available
    
    
    
98. MISRA G, Grohman R, Kazachkov M, Nowak-Wegrzyn A, et al
    Severe asthma and new-onset meat allergy in a child-could a new puppy be to blame?
    Ann Allergy Asthma Immunol. 2025 Jul 2:S1081-1206(25)00338.
    PubMed    
    
    
    
99. JUBRAN J, Tam JS
    Identifying patients with uncontrolled asthma or severe asthma: Does terminology matter?
    Ann Allergy Asthma Immunol. 2025;135:13-14.
    PubMed    
    
    
    
100. NGO SY, Anderson WC 3rd
     Weighing real-world studies when choosing a biologic for asthma: Insights and pitfalls.
     Ann Allergy Asthma Immunol. 2025;135:11-12.
     PubMed    
     
     
     June 2025
101. YE Z, Harrar SW, Beyene J, Mersha TB, et al
     Incorporating Type-2 inflammation status with clinical diagnosis and transcriptomics data in asthma risk classification.
     Ann Allergy Asthma Immunol. 2025 Jun 26:S1081-1206(25)00321.
     PubMed     Abstract available
     
     
     
102. OMAR W, Hardy P, Pappalardo AA
     National Asthma Control Program: Funding Simple, Effective Strategies to Reduce Asthma Burden and Costs.
     Ann Allergy Asthma Immunol. 2025 Jun 22:S1081-1206(25)00319.
     PubMed    
     
     
     
103. PALLER AS, Soong W, Boguniewicz M, Geng B, et al
     Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbidities.
     Ann Allergy Asthma Immunol. 2025 Jun 22:S1081-1206(25)00315.
     PubMed     Abstract available
     
     
     
104. AYACHE M, Khalid F
     Increased Likelihood of COVID-19-Related Asthma Exacerbation with Higher Eosinophil Count.
     Ann Allergy Asthma Immunol. 2025 Jun 21:S1081-1206(25)00316.
     PubMed    
     
     
     
105. HAMADA Y, Thomas D, McDonald VM, Harvey ES, et al
     Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab.
     Ann Allergy Asthma Immunol. 2025 Jun 20:S1081-1206(25)00309.
     PubMed     Abstract available
     
     
     
106. RAYNER DG, Bakaa L, Hoyte F, Perry TT, et al
     Triple therapy versus dual inhaler therapy for moderate-to-severe asthma: an updated systematic review and meta-analysis.
     Ann Allergy Asthma Immunol. 2025 Jun 12:S1081-1206(25)00287.
     PubMed     Abstract available
     
     
     
107. HENAO MP, Malerich J, George DR
     Impact of Language Barriers on Pulmonary Function and Asthma Control.
     Ann Allergy Asthma Immunol. 2025 Jun 8:S1081-1206(25)00278.
     PubMed     Abstract available
     
     
     
108. WU Y, Xu W
     Refining asthma disparity research: A call for multidimensional assessment of Aspergillus fumigatus sensitization.
     Ann Allergy Asthma Immunol. 2025;134:739-740.
     PubMed    
     
     
     
109. SALMON MK, Arya P, Backer V, Aanaes K, et al
     Psychometric validation of the Standard Tests for Asthma, Allergic Rhinitis, and Chronic Rhinosinusitis in the United States.
     Ann Allergy Asthma Immunol. 2025;134:671-675.
     PubMed     Abstract available
     
     
     
110. HAN JK, Silver J, Dhangar I, Veeranki P, et al
     Quantifying corticosteroid burden in chronic rhinosinusitis with nasal polyps: A retrospective US database study.
     Ann Allergy Asthma Immunol. 2025;134:685-693.
     PubMed     Abstract available
     
     
     May 2025
111. HAZLITT R, Nguyen K, Wilson A, Clark P, et al
     Diversity, Equity, and Inclusion in Asthma Clinical Trials: A Cross-Sectional Analysis.
     Ann Allergy Asthma Immunol. 2025 May 27:S1081-1206(25)00267.
     PubMed     Abstract available
     
     
     
112. MA R, Zhang C, Zhang Y, Tan H, et al
     The Impact of Respiratory Syncytial Virus on Asthma Development and Exacerbation.
     Ann Allergy Asthma Immunol. 2025 May 17:S1081-1206(25)00236.
     PubMed     Abstract available
     
     
     
113. PUPPELS GJ, Hourihane JO, Nico C, Chaoimh CN, et al
     Erratum to 'Highly accurate, noninvasive early identification of infants with a filaggrin loss-of-function mutation by in vivo Raman spectroscopy, followed from birth to 12 months' [Annals of Allergy, Asthma & Immunology, 134;4 (2025) 457-464].
     Ann Allergy Asthma Immunol. 2025 May 17:S1081-1206(25)00220.
     PubMed    
     
     
     
114. KIM Y, Moonie S, Kim I, Yoo JW, et al
     Increasing trend in asthma hospitalization among cannabis-dependent abusers and recreational cannabis legalizations (1998-2021).
     Ann Allergy Asthma Immunol. 2025 May 11:S1081-1206(25)00232.
     PubMed    
     
     
     
115. NARLA S, Silverberg JI
     Current updates in the epidemiology and comorbidities of atopic dermatitis.
     Ann Allergy Asthma Immunol. 2025 May 9:S1081-1206(25)00228.
     PubMed     Abstract available
     
     
     
116. DOWLING TC, Shah MM, Moulia DL, Hsu J, et al
     Recommended immunizations to reduce respiratory morbidity and mortality among US adults with asthma, by age.
     Ann Allergy Asthma Immunol. 2025;134:535-538.
     PubMed    
     
     
     
117. MURAI Y, Koya T, Koda H, Uji W, et al
     Dupilumab efficacy in relation to changes in club cell secretory protein 16.
     Ann Allergy Asthma Immunol. 2025;134:556-562.
     PubMed     Abstract available
     
     
     April 2025
118. NGUYEN VT, Roth K, Engelhardt E, Pearlstein A, et al
     The usual suspects: Respiratory Syncytial Virus and Rhinovirus drive asthma development and exacerbation.
     Ann Allergy Asthma Immunol. 2025 Apr 24:S1081-1206(25)00205.
     PubMed     Abstract available
     
     
     
119. SCOTT EA, Balasubramanian A, Brems JH, Wu TD, et al
     Peripheral eosinophil count as a biomarker for asthma exacerbation severity in acute care settings.
     Ann Allergy Asthma Immunol. 2025 Apr 18:S1081-1206(25)00183.
     PubMed     Abstract available
     
     
     
120. SCURLOCK AM, Fleischer DM, Toit GD, Arends NJT, et al
     Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-allergic Children with Atopic Comorbidities.
     Ann Allergy Asthma Immunol. 2025 Apr 7:S1081-1206(25)00179.
     PubMed     Abstract available
     
     
     
121. GARDNER DD, Gokani R, Hey-Hadavi J, Williams D, et al
     Healthcare-Seeking Behaviors for Acute Asthma: A US Cross-sectional Survey.
     Ann Allergy Asthma Immunol. 2025 Apr 3:S1081-1206(25)00175.
     PubMed     Abstract available
     
     
     
122. GRAYSON MH
     Asthma and evolving trends in allergy and immunology.
     Ann Allergy Asthma Immunol. 2025;134:369.
     PubMed    
     
     
     March 2025
123. KALRA S, Kalra D, Nagaraja N, Hlaing WM, et al
     Food Allergy and Asthma in a Nationally Representative Sample of Adolescents in the United States.
     Ann Allergy Asthma Immunol. 2025 Mar 28:S1081-1206(25)00152.
     PubMed    
     
     
     
124. TO M, Arimoto Y, Honda N, Furusho N, et al
     Elevated oxidative stress and steroid insensitivity in patients with asthma and high body fat percentage.
     Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00126.
     PubMed     Abstract available
     
     
     
125. FAN H, Ren Z, Zhang P, Zhou B, et al
     Increased asthma burden during and post the COVID-19 pandemic among U.S. adults.
     Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00123.
     PubMed    
     
     
     
126. VIINANEN A, Ilmarinen P, Mehtala J, Jylhava J, et al
     Factors associated with the development of severe asthma - a nationwide study (FINASTHMA).
     Ann Allergy Asthma Immunol. 2025 Mar 9:S1081-1206(25)00119.
     PubMed     Abstract available
     
     
     
127. GELB AF, Tashkin DP
     Utility of using thoracic computed tomography to measure lung function decline and detect unsuspected emphysema in severe asthma.
     Ann Allergy Asthma Immunol. 2025;134:253-254.
     PubMed    
     
     
     
128. TANABE N
     Further evidence for the roles of computed tomography in managing severe asthma.
     Ann Allergy Asthma Immunol. 2025;134:251-252.
     PubMed    
     
     
     
129. MATHUR SK, Silver J, MacKnight SD, Urosevic A, et al
     Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United States.
     Ann Allergy Asthma Immunol. 2025;134:341-350.
     PubMed     Abstract available
     
     
     February 2025
130. LUGOGO NL, Gilbert IA, Gandhi HN, Tkacz JP, et al
     Exacerbation burden in patients treated as intermittent or mild-persistent asthma using short-acting beta(2)-agonist rescue.
     Ann Allergy Asthma Immunol. 2025 Feb 24:S1081-1206(25)00088.
     PubMed     Abstract available
     
     
     
131. SKEEN E, Hamlington KL, De Keyser H, Liu AH, et al
     Managing Childhood Asthma with an Eye Toward Environmental, Social and Behavioral Features.
     Ann Allergy Asthma Immunol. 2025 Feb 24:S1081-1206(25)00092.
     PubMed     Abstract available
     
     
     
132. CEGOLON L, Filon FL, Lange JH
     Social determinants of health, Black race, sensitization to indoor molds and risk of severe asthma.
     Ann Allergy Asthma Immunol. 2025;134:125-126.
     PubMed    
     
     
     
133. GALANT SP
     Oscillometry-determined small airway dysfunction as a significant risk for poor asthma control and exacerbations.
     Ann Allergy Asthma Immunol. 2025;134:123-124.
     PubMed    
     
     
     January 2025
134. BRUZZESE JM, Cespedes A, Ainapudi V, Kingston S, et al
     Barriers to Seeing a Healthcare Provider among Rural Adolescents with Poorly Controlled Asthma.
     Ann Allergy Asthma Immunol. 2025 Jan 25:S1081-1206(25)00046.
     PubMed    
     
     
     
135. GREIG R, Chan R, Fardon TC, Lipworth BJ, et al
     Real world effects of tezepelumab on small airways dysfunction in severe refectory asthma.
     Ann Allergy Asthma Immunol. 2025 Jan 25:S1081-1206(25)00064.
     PubMed    
     
     
     
136. COTTINI M, Ventura L, Lombardi C, Landi M, et al
     Small airway dysfunction mediates the relationship between FeNO and asthma control.
     Ann Allergy Asthma Immunol. 2025 Jan 16:S1081-1206(25)00004.
     PubMed     Abstract available
     
     
     
137. LEE JK, Pollard SJ, Liu MC, Schleich F, et al
     Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.
     Ann Allergy Asthma Immunol. 2025 Jan 11:S1081-1206(25)00003.
     PubMed     Abstract available
     
     
     
138. OPPENHEIMER J, Casale T
     Care of asthma-a rapidly moving story.
     Ann Allergy Asthma Immunol. 2025;134:1-2.
     PubMed    
     
     
     December 2024
139. MILIGKOS M, Oh J, Kwon R, Konstantinou GNu, et al
     Epidemiology of asthma across the ages.
     Ann Allergy Asthma Immunol. 2024 Dec 12:S1081-1206(24)01727.
     PubMed     Abstract available
     
     
     
140. ELLIOTT MR, O'Connor AE, Marshall GD
     Corrigendum to 'Inflammatory pathways in patients with post-acute sequelae of COVID-19' [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 - 515].
     Ann Allergy Asthma Immunol. 2024 Dec 7:S1081-1206(24)01716.
     PubMed    
     
     
     
141. OU MC, Tsai RY, Li CP, Gau SY, et al
     Real-world effectiveness of mepolizumab in patients with asthma and comorbid nasal polyps.
     Ann Allergy Asthma Immunol. 2024;133:732-733.
     PubMed    
     
     
     
142. CHAN R, Kuo CR, Fardon T, Thouseef MJ, et al
     The interplay between skeletal muscle adiposity and radiographic features of airway remodeling in persistent asthma.
     Ann Allergy Asthma Immunol. 2024;133:626-627.
     PubMed    
     
     
     November 2024
143. ZHANG B, Yan M, Li C, Zhao J, et al
     Impact of asthma severity on surgical outcomes in patients with chronic rhinosinusitis comorbid with asthma.
     Ann Allergy Asthma Immunol. 2024 Nov 29:S1081-1206(24)01712.
     PubMed     Abstract available
     
     
     
144. LANZ MJ, Chipps B, Zeiger RS, Bacharier LB, et al
     Pediatric Asthma Impairment and Risk Questionnaire: Rationale and Development of a Composite Control Tool.
     Ann Allergy Asthma Immunol. 2024 Nov 28:S1081-1206(24)01711.
     PubMed     Abstract available
     
     
     
145. CONWAY AE, Marshall GD, Oppenheimer J, Shaker MS, et al
     Should Biologics Be Available for All Patients with Uncontrolled Asthma, Regardless? Absolutely and Here's Why.
     Ann Allergy Asthma Immunol. 2024 Nov 28:S1081-1206(24)01713.
     PubMed    
     
     
     
146. GREIMANN E, Freigeh GE, Wettenstein RP, Nelson B, et al
     Mild Asthma- What Matters to Patients and Parents.
     Ann Allergy Asthma Immunol. 2024 Nov 26:S1081-1206(24)01708.
     PubMed     Abstract available
     
     
     
147. DUCHARME FM, Chan R
     Oscillometry in the diagnosis, assessment, and monitoring of asthma in children and adults: review article.
     Ann Allergy Asthma Immunol. 2024 Nov 25:S1081-1206(24)01702.
     PubMed     Abstract available
     
     
     
148. GOCHICOA-RANGEL L, Vargas MH
     How best to choose an oscillometer and reference equations for your patients with asthma.
     Ann Allergy Asthma Immunol. 2024 Nov 16:S1081-1206(24)01681.
     PubMed     Abstract available
     
     
     
149. COTTINI M, Lombardi C, Comberiati P, Berti A, et al
     Oscillometry-defined small airways dysfunction as a treatable trait in asthma.
     Ann Allergy Asthma Immunol. 2024 Nov 15:S1081-1206(24)01658.
     PubMed     Abstract available
     
     
     
150. ZHANG W, Li L, Zhang Y, Dai J, et al
     Perturbations in the airway microbiome are associated with type 2 asthma phenotype and severity.
     Ann Allergy Asthma Immunol. 2024 Nov 14:S1081-1206(24)01657.
     PubMed     Abstract available
     
     
     
151. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
     Corrigendum to <'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology'> <[Annals of Allergy, Asthma & Immunolo
     Ann Allergy Asthma Immunol. 2024 Nov 2:S1081-1206(24)01630.
     PubMed    
     
     
     
152. YU JT, Gau SY, Li CP, Chang HC, et al
     Real-world association between cat ownership and asthma.
     Ann Allergy Asthma Immunol. 2024;133:613.
     PubMed    
     
     
     
153. SHEN CY, Li CP, Tsai RY, Chang HC, et al
     Infant urinary adrenal steroids and childhood asthma development.
     Ann Allergy Asthma Immunol. 2024;133:611-612.
     PubMed    
     
     
     
154. GRAYSON MH
     The future of allergy and immunology research: 2024 American College of Allergy, Asthma and Immunology Annals Fellow-in-Training award winners.
     Ann Allergy Asthma Immunol. 2024;133:505-506.
     PubMed    
     
     
     
155. ESCHENBACHER WH
     Treatment of type 2 inflammation: Targeted therapy for chronic rhinosinusitis with nasal polyps and asthma.
     Ann Allergy Asthma Immunol. 2024;133:497-498.
     PubMed    
     
     
     October 2024
156. RAO R, Han YY, Valentin-Rodriguez LA, Presto AA, et al
     Proximity to Fast-Food Restaurants and Pediatric Asthma Outcomes.
     Ann Allergy Asthma Immunol. 2024 Oct 26:S1081-1206(24)01631.
     PubMed    
     
     
     
157. RUPPRECHT C, Krishnaswamy G
     OSTEONECROSIS: A DISABLING DISEASE NOT TO BE IGNORED IN ASTHMA AND ATOPIC CONDITIONS.
     Ann Allergy Asthma Immunol. 2024 Oct 26:S1081-1206(24)01632.
     PubMed     Abstract available
     
     
     
158. GALLEGOS-KOYNER FJ, Hodo F, Barrera NI, Cerrud-Rodriguez RC, et al
     Opioid Use Disorder's Impact on Asthma Hospitalizations: A Propensity Matched Nationwide Study.
     Ann Allergy Asthma Immunol. 2024 Oct 18:S1081-1206(24)01577.
     PubMed     Abstract available
     
     
     
159. MANKA LA, Guntur VP, Stevens AD, Kolakowski C, et al
     The Supraglottic Index: An Indicator of Response to Laryngopharyngeal Reflux Therapy in Asthma.
     Ann Allergy Asthma Immunol. 2024 Oct 15:S1081-1206(24)01573.
     PubMed     Abstract available
     
     
     
160. ZIDAN E, Wilson G, Shin JJ, Chupp G, et al
     The Next Frontier: Defining and Optimizing Treatments for Patients with T2 Low Asthma.
     Ann Allergy Asthma Immunol. 2024 Oct 14:S1081-1206(24)01571.
     PubMed    
     
     
     
161. SELUK L, Davis AE, Rhoads S, Wechsler ME, et al
     Novel asthma treatments: Advancing Beyond Approved Novel Step-Up Therapies for Asthma.
     Ann Allergy Asthma Immunol. 2024 Oct 9:S1081-1206(24)01552.
     PubMed     Abstract available
     
     
     
162. MAILHOT-LAROUCHE S, Celis-Preciado C, Heaney LG, Couillard S, et al
     Identifying Super-Responders: a Review of the Road to Asthma Remission.
     Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01559.
     PubMed     Abstract available
     
     
     
163. GREIG R, Stewart K, Chan R, Lipworth B, et al
     Assessment of bronchodilator responsiveness using low frequency impedance in type 2 high uncontrolled severe asthma.
     Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01570.
     PubMed    
     
     
     
164. BUSSE WW
     The Role of Biologics in Inducing Remission in Asthma.
     Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01557.
     PubMed     Abstract available
     
     
     
165. MIYATA Y, Tanaka A, Ebato T, Kashima A, et al
     Baseline forced oscillation technique predicting lack of exacerbations in adult with asthma: A 12-month prospective.
     Ann Allergy Asthma Immunol. 2024 Oct 4:S1081-1206(24)01553.
     PubMed     Abstract available
     
     
     
166. WEINBERGER MM, Hendeles L
     Biologics for asthma and comorbid nasal polyps.
     Ann Allergy Asthma Immunol. 2024;133:356-357.
     PubMed    
     
     
     
167. CORELLI ER, Peebles RS Jr
     Race toward more equitable pulmonary function testing?
     Ann Allergy Asthma Immunol. 2024;133:362-363.
     PubMed    
     
     
     
168. MCCULLOCH MR, Bothwell S, Brinton JT, Anderson WC 3rd, et al
     Effect of electronic medication monitoring on asthma outcomes in a multidisciplinary pediatric severe asthma clinic.
     Ann Allergy Asthma Immunol. 2024 Oct 1:S1081-1206(24)01533.
     PubMed    
     
     
     September 2024
169. BLOODWORTH MH, Staso PJ, Huang S, Farber-Eger E, et al
     Metabolic and weight components' impact on incident asthma using a real-world cohort.
     Ann Allergy Asthma Immunol. 2024 Sep 16:S1081-1206(24)01509.
     PubMed     Abstract available
     
     
     
170. CHAN R, Lipworth B
     Airway oscillometry in asthma - present and future perspectives.
     Ann Allergy Asthma Immunol. 2024 Sep 14:S1081-1206(24)01529.
     PubMed    
     
     
     
171. GLEESON PK, Morales KH, Kerlin MP, Fadugba OO, et al
     Asthma exacerbations in Aspergillus fumigatus-sensitized adults with asthma differs by race.
     Ann Allergy Asthma Immunol. 2024 Sep 9:S1081-1206(24)01504.
     PubMed     Abstract available
     
     
     
172. SIM DW, Choi S, Jeong J, Lee SY, et al
     Computed tomography-based measurements associated with rapid lung function decline in severe asthma.
     Ann Allergy Asthma Immunol. 2024 Sep 5:S1081-1206(24)01502.
     PubMed     Abstract available
     
     
     
173. KAIDASHEV I, Ditiatkovskaya E
     Managing Asthma and Allergies during the Russo-Ukrainian War.
     Ann Allergy Asthma Immunol. 2024 Sep 3:S1081-1206(24)00573.
     PubMed    
     
     
     
174. SHAMIM J
     The relationship of height and asthma.
     Ann Allergy Asthma Immunol. 2024;133:352.
     PubMed    
     
     
     
175. PHILIPENKO BS, Davis B, Cockcroft DW
     To stop or not to stop an asthma biologic, that is the question.
     Ann Allergy Asthma Immunol. 2024;133:236-237.
     PubMed    
     
     
     
176. BRIGHTLING CE, Caminati M, Llanos JP, Caveney S, et al
     Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION study.
     Ann Allergy Asthma Immunol. 2024;133:310-317.
     PubMed     Abstract available
     
     
     August 2024
177. HAYASHI Y, Tanabe N, Shimizu K, Maetani T, et al
     Lower skeletal muscle density and airway structure on computed tomography in asthma (12/15 words).
     Ann Allergy Asthma Immunol. 2024 Aug 21:S1081-1206(24)00527.
     PubMed     Abstract available
     
     
     
178. HAGWOOD SR, Elliott M, Marshall GD
     Comparing Prevalence of Food Allergy in Exercise-induced Bronchoconstriction vs. Asthma.
     Ann Allergy Asthma Immunol. 2024 Aug 13:S1081-1206(24)00496.
     PubMed    
     
     
     
179. ROTBLAT D, Wei C, Reyna GC, Grabie Y, et al
     Impact of Cannabinoid Use on Acute Pulmonary Outcomes in Hospitalized Asthmatic Patients.
     Ann Allergy Asthma Immunol. 2024 Aug 3:S1081-1206(24)00486.
     PubMed    
     
     
     
180. MALDONADO-PUEBLA M, Ledford D, Cardet JC
     The minimal clinically important difference in the Asthma Impairment and Risk Questionnaire.
     Ann Allergy Asthma Immunol. 2024;133:123-124.
     PubMed    
     
     
     
181. STEWART K, Kuo CR, Chan R, Lipworth B, et al
     Evaluating an electronic device to monitor the type 2 high unified airway response to dupilumab.
     Ann Allergy Asthma Immunol. 2024;133:211-213.
     PubMed    
     
     
     July 2024
182. SOTO-RETES L, Milagro J, Crespo-Lessmann A, Curto E, et al
     Parasympathetic nervous system: a key role in control and mood disorders in patients with asthma.
     Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00480.
     PubMed     Abstract available
     
     
     
183. FITZPATRICK AM, Mohammad AF, Desher K, Mutic AD, et al
     Clinical and inflammatory features of traffic-related diesel exposure in children with asthma.
     Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00457.
     PubMed     Abstract available
     
     
     
184. HAN YY, Celedon JC
     The Effects of Violence and Related Stress on Asthma.
     Ann Allergy Asthma Immunol. 2024 Jul 26:S1081-1206(24)00479.
     PubMed     Abstract available
     
     
     
185. FRUEH L, Sharma R, Sheffield PE, Clougherty JE, et al
     Community Violence and Asthma: A Review.
     Ann Allergy Asthma Immunol. 2024 Jul 20:S1081-1206(24)00453.
     PubMed     Abstract available
     
     
     
186. CHIARELLA SE, Garcia-Guaqueta DP, Drake LY, Dixon RE, et al
     Sex differences in sociodemographic, clinical, and laboratory variables in childhood asthma: A birth cohort study.
     Ann Allergy Asthma Immunol. 2024 Jul 15:S1081-1206(24)00426.
     PubMed     Abstract available
     
     
     
187. TAJIRI T, Suzuki M, Nishiyama H, Ozawa Y, et al
     Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma: A prospective study.
     Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00422.
     PubMed     Abstract available
     
     
     
188. BERNSTEIN JA, Silver J, Packnett E, Lew CR, et al
     Real-world unified airway benefits of mepolizumab: effectiveness in patients with asthma and comorbid nasal polyps.
     Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00421.
     PubMed     Abstract available
     
     
     
189. SIM S, Jang JH, Park HS
     Contribution of non-neuronal cholinergic system to T2-low airway inflammation in severe asthma.
     Ann Allergy Asthma Immunol. 2024;133:7-8.
     PubMed    
     
     
     
190. GUTIERREZ CG, Bukstein DA
     Functionality of the Asthma Impairment and Risk Questionnaire and its implications in shared decision-making.
     Ann Allergy Asthma Immunol. 2024;133:5-6.
     PubMed    
     
     
     
191. HARRIS D, Borish L
     How we treat type 2 low asthma.
     Ann Allergy Asthma Immunol. 2024;133:43-46.
     PubMed    
     
     
     
192. MULLUR J, Buchheit KM
     Correction to "Aspirin-exacerbated respiratory disease" by Mullur J and Buchheit KM (Ann Allergy Asthma Immunol 131 (2023) 317-324).
     Ann Allergy Asthma Immunol. 2024;133:118.
     PubMed    
     
     
     June 2024
193. TRASANDE L
     The Role of Plastics in Allergy, Immunology and Human Health: What the Clinician Needs to Know and Can Do About It.
     Ann Allergy Asthma Immunol. 2024 Jun 28:S1081-1206(24)00417.
     PubMed     Abstract available
     
     
     
194. ADELEKE S, Ongtengco A, Youssef C, Hardy P, et al
     Addressing Critical Barriers for Sustainability of Asthma Stock Inhaler Policy Implementation and Resultant Programming.
     Ann Allergy Asthma Immunol. 2024 Jun 26:S1081-1206(24)00373.
     PubMed     Abstract available
     
     
     
195. BAREILLE P, Forth R, Imber V, Bondarenko I, et al
     Once-Daily Fluticasone Furoate/Vilanterol Versus Once-Daily Fluticasone Furoate in Asthma Patients Aged 5-17 Years.
     Ann Allergy Asthma Immunol. 2024 Jun 25:S1081-1206(24)00376.
     PubMed     Abstract available
     
     
     
196. MISHRA PE, Han YY, Hill K, Rosser FJ, et al
     Persistent cat ownership and asthma in a longitudinal study of Puerto Rican youth.
     Ann Allergy Asthma Immunol. 2024 Jun 24:S1081-1206(24)00375.
     PubMed     Abstract available
     
     
     
197. ZAEH SE, Zimmerman ZE, Eakin MN, Chupp G, et al
     Adoption and Implementation of Maintenance and Reliever Therapy for Adults with Moderate to Severe Asthma.
     Ann Allergy Asthma Immunol. 2024 Jun 17:S1081-1206(24)00363.
     PubMed     Abstract available
     
     
     
198. ZEIGER JS, Silvers WS, Zeiger RS
     Comparison of Cannabis Knowledge, Attitudes, and Practice (KAP) between Allergists and Allergic and Asthmatic Patients.
     Ann Allergy Asthma Immunol. 2024 Jun 13:S1081-1206(24)00347.
     PubMed    
     
     
     
199. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
     Use of Vaccines in Patients Receiving Dupilumab, A Systematic Review and Expert Delphi Consensus Recommendation: A position paper of the American College of Allergy, Asthma and Immunology.
     Ann Allergy Asthma Immunol. 2024 Jun 5:S1081-1206(24)00337.
     PubMed     Abstract available
     
     
     
200. SEDAGHAT AR, Phillips KM
     Unifying the airway through multiomics.
     Ann Allergy Asthma Immunol. 2024;132:667-668.
     PubMed    
     
     
     May 2024
201. BELLANTI JA, Settipane RA
     Legacy of Congressman George Miller O'Brien: Advocate for the patient with asthma and allergic disease.
     Ann Allergy Asthma Immunol. 2024 May 31:S1081-1206(24)00308.
     PubMed    
     
     
     
202. PETERSEN M, Bingemann TA
     Correction to "Navigating allergic disease in military accessions: A crucial role for civilian allergists" (Ann Allergy Asthma Immunol 132 (2024) 547-548).
     Ann Allergy Asthma Immunol. 2024 May 18:S1081-1206(24)00285.
     PubMed    
     
     
     
203. CHUPP G, Murphy KR, Gandhi HN, Gilbert I, et al
     Asthma control in the United States: relationships between short-acting beta(2)-agonist and systemic corticosteroid use.
     Ann Allergy Asthma Immunol. 2024 May 11:S1081-1206(24)00287.
     PubMed     Abstract available
     
     
     
204. KLOEPFER KM, Kennedy JL
     Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
     Ann Allergy Asthma Immunol. 2024;132:553-554.
     PubMed    
     
     
     
205. KATIAL RK, Hoyte FCL
     Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States.
     Ann Allergy Asthma Immunol. 2024;132:551-552.
     PubMed    
     
     
     
206. BEIGELMAN A, Goss CW, Wang J, Srinivasan M, et al
     Azithromycin therapy in infants hospitalized for respiratory syncytial virus bronchiolitis: Airway matrix metalloproteinase-9 levels and subsequent recurrent wheeze.
     Ann Allergy Asthma Immunol. 2024;132:623-629.
     PubMed     Abstract available
     
     
     April 2024
207. TURI KN, Li Y, Xu Y, Gebretsadik T, et al
     The Association of Infant Urinary Adrenal Steroids with the Risk of Childhood Asthma Development.
     Ann Allergy Asthma Immunol. 2024 Apr 15:S1081-1206(24)00215.
     PubMed     Abstract available
     
     
     
208. WOO SD, Park HS, Yang EM, Ban GY, et al
     8-Iso-prostaglandin F2alpha as a biomarker of T2-low airway inflammation and remodeling in adult asthma.
     Ann Allergy Asthma Immunol. 2024 Apr 12:S1081-1206(24)00214.
     PubMed     Abstract available
     
     
     March 2024
209. MOTA D, Martins C, Puga N, Moreira A, et al
     Asthma and allergy screening in elite football athletes: is it worth it?
     Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00205.
     PubMed    
     
     
     
210. LEE PH, An M, Hwang D, Jang AS, et al
     Impact of circulating angiomotin and angiostatin on clinical variables in patients with asthma.
     Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00207.
     PubMed    
     
     
     
211. HUANG D, Zhang L, Liu Y, Wang J, et al
     Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.
     Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00150.
     PubMed     Abstract available
     
     
     
212. ZAHRAEI HN, Schleich F, Louis G, Gerday S, et al
     Evidence for two clusters among non-eosinophilic asthmatics.
     Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00154.
     PubMed     Abstract available
     
     
     
213. CHIPPS BE, Zeiger RS, Beuther DA, Wise RA, et al
     Advancing assessment of asthma control with a composite tool: the Asthma Impairment and Risk Questionnaire.
     Ann Allergy Asthma Immunol. 2024 Mar 15:S1081-1206(24)00153.
     PubMed     Abstract available
     
     
     
214. LI Y, Hong X, Chandran A, Keet CA, et al
     Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities.
     Ann Allergy Asthma Immunol. 2024 Mar 12:S1081-1206(24)00143.
     PubMed     Abstract available
     
     
     
215. GWAK DY, Tea JC, Fatima FN, Palka JM, et al
     Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life.
     Ann Allergy Asthma Immunol. 2024 Mar 6:S1081-1206(24)00141.
     PubMed     Abstract available
     
     
     February 2024
216. CETIN GP, Yilmaz I
     What should be the outcome of biological treatment in asthma: "Remission on Treatment" or "Super-responder".
     Ann Allergy Asthma Immunol. 2024 Feb 23:S1081-1206(24)00103.
     PubMed    
     
     
     
217. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
     Lower paraspinal muscle density is associated with small airway dysfunction in women with persistent asthma.
     Ann Allergy Asthma Immunol. 2024 Feb 22:S1081-1206(24)00089.
     PubMed    
     
     
     January 2024
218. CHEN C, Song X, Murdock DJ, Marcus A, et al
     Association between allergic conditions and COVID-19 susceptibility and outcomes.
     Ann Allergy Asthma Immunol. 2024 Jan 17:S1081-1206(24)00011.
     PubMed     Abstract available
     
     
     November 2023
219. KIM BE, Hui-Beckman JW, Nevid MZ, Goleva E, et al
     Air pollutants contribute to epithelial barrier dysfunction and allergic diseases.
     Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01462.
     PubMed     Abstract available
     
     
     
220. GEVAERT P, Mullol J, Saenz R, Ko J, et al
     Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
     Ann Allergy Asthma Immunol. 2023 Nov 9:S1081-1206(23)01393.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum